论文部分内容阅读
目的研究常规治疗药物联合普伐他汀治疗急性心肌梗死的疗效。方法 96例心肌梗死患者随机分为对照组和观察组,每组48例。对照组使用常规药物进行治疗,观察组在采用常规药物治疗的基础上再给予普伐他汀的治疗,比较30天后两组患者的心血管事件终点发生率。结果观察组的心肌再梗死率,不稳定心绞痛率及死亡率均明显低于对照组(P<0.05)。结论常规药物联合普伐他汀的治疗方案可使急性心肌梗死患者的心血管事件终点发生率明显下降,值得在临床上进行推广。
Objective To study the curative effect of conventional therapy combined with pravastatin on acute myocardial infarction. Methods 96 cases of myocardial infarction were randomly divided into control group and observation group, 48 cases in each group. The control group was treated with conventional drugs. The observation group was treated with pravastatin on the basis of conventional drug treatment. The incidence of cardiovascular events after 30 days was compared between the two groups. Results The myocardial infarction rate, unstable angina and mortality in observation group were significantly lower than those in control group (P <0.05). Conclusion The combination of conventional drugs and pravastatin can significantly reduce the incidence of cardiovascular events in patients with acute myocardial infarction and is worthy of clinical promotion.